Freenome Reports Third Quarter 2026 Financial Results
– Third-quarter results reflect revenue of $183.5 million driven by the FDA approval of SimpleScreen™ CRC –
Covered in this story
Analyst targets on California Resources Corp
- UBS: at $53.7 · target $68 by Oct 2027 · Buy via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on California Resources Corp →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.